Please assess the completion status of the following clinical trial:

Trial Title: Myocardial Stress Perfusion Computed Tomography in the Evaluation of Patients With Acute Chest Pain Using a Novel 3rd Generation Dual-source CT System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subject must present with symptoms of acute but atypical or recurrent chest pain.~* Subject must have been referred for cardiac CT angiography OR subject must have undergone clinically indicated SPECT with positive or equivocal findings OR subject must have undergone clinically indicated SPECT with prior cardiac CT angiography that showed moderate or severe stenosis.~* Subject must be 18-85 years of age.~* Subject must provide written informed consent prior to any study-related procedures being conducted.~* Subject must be willing to comply with all clinical study procedures.~Exclusion Criteria:~* Subject is a pregnant or nursing female.~* Subject has severe asthma or COPD requiring frequent inhaler use.~* Subject has prior diagnosis of obstructive CAD that has not been revascularized.~* Subject with implanted rhythm devices (pacemaker, defibrillator).~* Subject has significant arrhythmia.~* Subject has high grade heart block.~* Subject has resting heart rate \< 45 bpm, systolic blood pressure \<90 mm Hg, or has consumed caffeine within the last 12 hours.~* Subject has an acute psychiatric disorder.~* Subject is unwilling to comply with the requirements of the protocol.~* Subject has previously entered this study.~* Subject has an allergy against iodinated contrast or pharmaceutical stressors used in this study.~* Subject suffers from claustrophobia.~* Subject has impaired renal function (creatinine \> 1.5 mg/dl).~* Subject is in unstable condition.~* ST-elevations, new transient ST changes greater than 0.05mV or T-wave inversions with symptoms.~* Subject cannot safely be administered Lexiscan per prescribing information as as determined by investigator.~* Subject has received interventional (PCI, stenting) or surgical (CABG) treatment that may alter the cardiac condition regarding myocardial perfusion status and/or stenosis degree between cardiac CTA, SPECT, and/or CT stress perfusion studies.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Myocardial Stress CT Perfusion (Type: EXPERIMENTAL): Dynamic volume CT myocardial perfusion using the experimental scanner (Force, Siemens), applying the dynamic shuttle mode will be used to rapidly cover the entire cardiac anatomy during infusion of a contrast medium bolus for monitoring bolus passage through the left ventricular myocardium.

Based on this trial design, predict the completion outcome and termination type (if applicable).